TerrAscend (OTCMKTS:TSNDF) Stock Price Down 8.5% - Should You Sell?

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report)'s share price dropped 8.5% during trading on Monday . The company traded as low as $0.32 and last traded at $0.32. Approximately 522,642 shares were traded during mid-day trading, a decline of 23% from the average daily volume of 675,144 shares. The stock had previously closed at $0.35.

TerrAscend Stock Down 11.2 %

The company has a debt-to-equity ratio of 0.81, a current ratio of 1.35 and a quick ratio of 0.69. The firm has a 50-day moving average price of $0.40 and a two-hundred day moving average price of $0.63. The company has a market capitalization of $114.13 million, a price-to-earnings ratio of -1.39 and a beta of 1.55.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.03) by $0.04. The company had revenue of $74.35 million during the quarter, compared to the consensus estimate of $72.37 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%. As a group, sell-side analysts anticipate that TerrAscend Corp. will post -0.14 earnings per share for the current fiscal year.

TerrAscend Company Profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.